Document ID: chunk:federal_register_of_legislation:C2024C00455:front:0:p4
Version: federal_register_of_legislation:C2024C00455
Segment Type: other
Provision Reference: 
Character Range: 8450–11909

certain amended specifications
114A Objection cannot be taken to certain amended specifications
115 Restriction on recovery of damages etc.
116 Interpretation of amended specifications
Chapter 11—Infringement
Part 1—Infringement and infringement proceedings
117 Infringement by supply of products
118 Infringement exemptions: use in or on foreign vessels, aircraft or vehicles
119 Infringement exemptions: prior use
119A Infringement exemptions: acts for obtaining regulatory approval of pharmaceuticals
119B Infringement exemptions: acts for obtaining regulatory approval (non‑pharmaceuticals)
119C Infringement exemptions: acts for experimental purposes
120 Infringement proceedings
121 Counter‑claim for revocation of patent
121A Burden of proof—infringement of patent for a process
122 Relief for infringement of patent
123 Innocent infringement
Part 2—Non‑infringement declarations
124 Interpretation
125 Application for non‑infringement declaration
126 Proceedings for non‑infringement declarations
127 Effect of non‑infringement declarations
Part 3—Unjustified threats of infringement proceedings
128 Application for relief from unjustified threats
129 Court's power to grant relief if threats related to a standard patent or standard patent application
129A Threats related to an innovation patent application or innovation patent and court's power to grant relief
130 Counter‑claim for infringement
131 Notification of patent not a threat
132 Liability of legal practitioner or patent attorney
Chapter 12—Compulsory licences and revocation of patents
Part 1—Introduction
132A Simplified outline of this Chapter
Part 2—Compulsory licences (general)
132B Simplified outline of this Part
133 Compulsory licences—general
134 Revocation of patent after grant of compulsory licence under section 133
136 Orders to be consistent with international agreements
136A Dealing with allegation of contravention of application law
Part 3—Patented pharmaceutical invention compulsory licences (for manufacture and export to eligible importing countries)
Division 1—Introduction
136B Simplified outline of this Part
136C Relationship between Parts 2 and 3
Division 2—Patented pharmaceutical invention compulsory licences
136D PPI compulsory licences—applications for orders
136E PPI compulsory licences—orders
136F PPI compulsory licences—terms
136G PPI compulsory licences—amendment
136H PPI compulsory licences—revocation
Division 3—Remuneration
136J PPI compulsory licences—remuneration
Division 4—General
136K PPI compulsory licences—nature of orders
136L PPI compulsory licences—consistency of orders with international agreements
136M PPI compulsory licences—applications heard together
Part 4—Surrender and revocation of patents
136N Simplified outline of this Part
137 Revocation on surrender of patent
138 Revocation of patents in other circumstances
Part 5—Other matters
138A Simplified outline of this Part
139 Parties to proceedings
140 Commissioner to be given copies of orders
Chapter 13—Withdrawal and lapsing of applications and ceasing of patents
141 Withdrawal of applications
142 Lapsing of applications
143 Ceasing of patents
143A Ceasing of innovation patents
143B Payment of fees
Chapter 14—Contracts
145 Termination of contract after patent ceases to be in force
Chapter 15—Special provisions relating to associated technology
147 Certificate by Director as to associated technology
148 Lapsing etc. of applications
149 Revocation of direction